{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:45:48Z","timestamp":1649119548701},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.transproceed.2018.04.044","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T02:37:53Z","timestamp":1524019073000},"page":"3181-3184","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transplantation Opportunities of Hepatitis C Virus\u2013Seropositive Patients on the Kidney Waiting List"],"prefix":"10.1016","volume":"50","author":[{"given":"A.","family":"Oruc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.04.044_bib1","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","article-title":"Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS","volume":"65","author":"Fissell","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2018.04.044_bib2","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/ajt.12835","article-title":"Hepatitis C virus infection and kidney transplantation in 2014: what\u2019s new?","volume":"14","author":"Baid-Agrawal","year":"2014","journal-title":"Am J Transpl"},{"key":"10.1016\/j.transproceed.2018.04.044_bib3","series-title":"Registry of the nephrology, dialysis and transplantation in Turkey: Registry 2016, Ministry of Health and Turkish Society of Nephrology Joint Report","author":"Suleymanlar","year":"2017"},{"key":"10.1016\/j.transproceed.2018.04.044_bib4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3748\/wjg.v21.i2.408","article-title":"Management of hepatitis C in patients with chronic kidney disease","volume":"21","author":"Carvalho-Filho","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.transproceed.2018.04.044_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4254\/wjh.v9.i4.180","article-title":"Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation","volume":"8","author":"Cholongitas","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.transproceed.2018.04.044_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.transproceed.2016.12.009","article-title":"Risk factors affecting graft and patient survivals after transplantation from deceased donors in a developing country: a single-center experience","volume":"49","author":"Ayar","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.04.044_bib7","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/00007890-200004150-00045","article-title":"Histopathological features hepatitis C in renal transplant candidates (see comment)","volume":"69","author":"Martin","year":"2000","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.transproceed.2018.04.044_bib8","first-page":"277","article-title":"Progression of hepatic fibrosis faster than expected in Anti-HCV (+) renal transplant cases (Abstract)","volume":"13","author":"Dilek","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2018.04.044_bib9","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/TP.0000000000000479","article-title":"Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts","volume":"99","author":"Scalea","year":"2015","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.transproceed.2018.04.044_bib10","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1600-6143.2010.03091.x","article-title":"Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients","volume":"10","author":"Kucirka","year":"2010","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.transproceed.2018.04.044_bib11","first-page":"516","article-title":"The effect of dialysis duration on marginal donor transplantation decision in dialysis patients (Abstract)","volume":"28","author":"Korkmaz","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2018.04.044_bib12","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(15)00349-9","article-title":"Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4\u20135 chronic kidney disease (the C-SURFER study): a combination phase 3 study","volume":"386","author":"Roth","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2018.04.044_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/1744-9987.12407","article-title":"Effect and safety of Daclatasvir-Asunaprevir combination therapy for chronic hepatitis C virus genotype 1b -infected patients on hemodialysis","volume":"20","author":"Miyazaki","year":"2016","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transproceed.2018.04.044_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1600-6143.2003.00057.x","article-title":"Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance","volume":"3","author":"Cruzado","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.04.044_bib15","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1097\/01.ASN.0000079613.81511.3C","article-title":"Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation","volume":"14","author":"Kamar","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.04.044_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/sdi.12456","article-title":"Direct-acting antiviral agents for the hepatitis C virus-infected chronic kidney disease population: the dawn of a new era","volume":"29","author":"Kusnir","year":"2016","journal-title":"Semin Dial"},{"key":"10.1016\/j.transproceed.2018.04.044_bib17","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/ajt.13518","article-title":"Efficacy and safety of Sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation","volume":"16","author":"Kamar","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.04.044_bib18","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/ajt.13620","article-title":"Successful treatment of hepatitis C in renal transplant recipients with direct-acting antiviral agents","volume":"16","author":"Sawinski","year":"2016","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.transproceed.2018.04.044_bib19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/tri.12954","article-title":"Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study","volume":"30","author":"Bhamidimarri","year":"2017","journal-title":"Transpl Int"},{"issue":"11","key":"10.1016\/j.transproceed.2018.04.044_bib20","first-page":"e890","article-title":"Early results of pilot study using hepatitis C virus (HCV) positive kidneys to transplant HCV infected patients with end-stage renal disease allowing for successful interferon-free direct acting antiviral therapy after transplantation","volume":"8","author":"Gallegos-Orozco","year":"2016","journal-title":"Cureus"},{"key":"10.1016\/j.transproceed.2018.04.044_bib21","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1681\/ASN.2016010030","article-title":"Hepatitis C virus infection in chronic kidney disease","volume":"27","author":"Ladino","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"Suppl. 1","key":"10.1016\/j.transproceed.2018.04.044_bib22","first-page":"155","article-title":"Effect of direct acting antiviral agents in kidney transplantation candidate dialyzed patients with chronic hepatitis C virus infection (abstract)","volume":"26","author":"Oruc","year":"2017","journal-title":"Turkish Nephrol Dial Transplant J"},{"key":"10.1016\/j.transproceed.2018.04.044_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000452730","article-title":"Hepatitis C treatment in chronic kidney disease patients: the kidney disease improving global outcomes perspective","volume":"43","author":"Jadoul","year":"2017","journal-title":"Blood Purif"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518306146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518306146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T11:00:13Z","timestamp":1548327613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518306146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0041134518306146"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.04.044","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transplantation Opportunities of Hepatitis C Virus\u2013Seropositive Patients on the Kidney Waiting List","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}